Literature DB >> 16443585

Effect of body weight on testosterone/estradiol ratio in oligozoospermic patients.

I Fejes1, S Koloszár, Z Závaczki, J Daru, J Szöllösi, A Pál.   

Abstract

To evaluate the effect of body mass on the hormonal and semen profiles of subfertile men with oligozoospemia, sperm concentration and reproductive hormone levels were compared in two body mass index (BMI) groups: underweight or normal weight patients (BMI = 25 kg/m2) vs. overweight or obese patients (BMI > 25 kg/m2). The mean BMI was 27 +/- 4.6 kg/m2. The testosterone/estradiol ratio was significantly reduced in the high BMI group as compared to the low BMI group (17 +/- 4 vs. 12 +/- 3; p < 0.05). A similar difference was found in the sperm concentration (11.2 +/- 3.16 x 10(6)/ml vs. 8.1 +/- 2.6 x 10(6)/ml). A nonsignificant difference was found in the LH/FSH ratio (1.41 +/- 0.64 vs. 1.63 +/- 0.72). We concluded that obesity and the consequent estrogen excess decrease the sperm concentration by influencing the hypothalamo-pituitary system.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16443585     DOI: 10.1080/01485010500315479

Source DB:  PubMed          Journal:  Arch Androl        ISSN: 0148-5016


  31 in total

1.  Sperm motility inversely correlates with seminal leptin levels in idiopathic asthenozoospermia.

Authors:  Jianhua Guo; Yang Zhao; Weiying Huang; Wei Hu; Jianjun Gu; Chuhong Chen; Juan Zhou; Yubing Peng; Min Gong; Zhong Wang
Journal:  Int J Clin Exp Med       Date:  2014-10-15

Review 2.  The Disappearing Sperms: Analysis of Reports Published Between 1980 and 2015.

Authors:  Pallav Sengupta; Sulagna Dutta; Elzbieta Krajewska-Kulak
Journal:  Am J Mens Health       Date:  2016-04-19

Review 3.  Hormone-Based Treatments in Subfertile Males.

Authors:  Darshan P Patel; Jason C Chandrapal; James M Hotaling
Journal:  Curr Urol Rep       Date:  2016-08       Impact factor: 3.092

4.  Reduction of calprotectin and phosphate during testosterone therapy in aging men: a randomized controlled trial.

Authors:  L Pedersen; L L Christensen; S M Pedersen; M Andersen
Journal:  J Endocrinol Invest       Date:  2016-12-20       Impact factor: 4.256

Review 5.  Abnormalities of Reproductive Function in Male Obesity Before and After Bariatric Surgery-A Comprehensive Review.

Authors:  Alberto Rosenblatt; Joel Faintuch; Ivan Cecconello
Journal:  Obes Surg       Date:  2015-07       Impact factor: 4.129

6.  Analysis of the Functional Aspects of Sperm and Testicular Oxidative Stress in Individuals Undergoing Metabolic Surgery.

Authors:  Roberta Maria Fariello; Renata Cristina de Carvalho; Deborah M Spaine; Rhayza R Andretta; Elesiário M Caetano; Gustavo P D Sá; Agnaldo P Cedenho; Renato Fraietta
Journal:  Obes Surg       Date:  2021-03-25       Impact factor: 4.129

Review 7.  BMI in relation to sperm count: an updated systematic review and collaborative meta-analysis.

Authors:  N Sermondade; C Faure; L Fezeu; A G Shayeb; J P Bonde; T K Jensen; M Van Wely; J Cao; A C Martini; M Eskandar; J E Chavarro; S Koloszar; J M Twigt; C H Ramlau-Hansen; E Borges; F Lotti; R P M Steegers-Theunissen; B Zorn; A J Polotsky; S La Vignera; B Eskenazi; K Tremellen; E V Magnusdottir; I Fejes; S Hercberg; R Lévy; S Czernichow
Journal:  Hum Reprod Update       Date:  2012-12-12       Impact factor: 15.610

8.  Body mass index in relation to semen quality, sperm DNA integrity, and serum reproductive hormone levels among men attending an infertility clinic.

Authors:  Jorge E Chavarro; Thomas L Toth; Diane L Wright; John D Meeker; Russ Hauser
Journal:  Fertil Steril       Date:  2009-03-03       Impact factor: 7.329

9.  Treatment of male infertility secondary to morbid obesity.

Authors:  Mara Y Roth; John K Amory; Stephanie T Page
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-06-03

Review 10.  Enclomiphene citrate for the treatment of secondary male hypogonadism.

Authors:  Katherine M Rodriguez; Alexander W Pastuszak; Larry I Lipshultz
Journal:  Expert Opin Pharmacother       Date:  2016-07-04       Impact factor: 3.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.